Search
for
Sort by
Research 30 of 1000+
- Synthetic hair implantations continue; serious complications result
- Synthetic hair implantations continue; serious complications result
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection
- Complications of Mesotherapy
- Skin disorders in diabetes mellitus
- P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- Complications of Hair Transplantation
- Serious Delayed Hair Toe Tourniquet Syndrome with Bone Erosion and Flexor Tendon Lesion
- Nonpruritic urticaria – a sign of serious systemic disease
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Cutaneous manifestations of systemic infection in children
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss
- Complications of Rhytidectomy
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- BCG'osis
- Manifestation of pityriasis amiantacea following initiation of minoxidil
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Subcutaneous emphysema resulting from liquid nitrogen spray
- Tofacitinib therapy for children with severe alopecia areata
- Eyebrow Loss